Documents reviewing the research on peptides note lack of good evidence of efficacy or safety. Yet an FDA panel will consider easing access to them later this month.
(Image credit: Svitlana Pietukhova/iStockphoto)
FDA scientists flag concerns with peptides, the trendy molecules RFK Jr. supports
Documents reviewing the research on peptides note lack of good evidence of efficacy or safety. Yet an FDA panel will consider easing access to them later this month.
schedule
18:32
visibility
49 views
Source: NPR News
newspaper
DW News 
TechCrunch 
The Guardian 
